This website uses cookies to improve the site and user experience. By continuing to browse this site,
you agree to accept our use of cookies. For more information, please review our Cookies Policy
ASCO® 2021
Presentations
Brentuximab Vedotin | Diffuse Large B-cell Lymphoma | Abstract TPS7571
Brentuximab Vedotin in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (Trial in Progress)
Brentuximab Vedotin | Hodgkin Lymphoma | Abstract 7528
Brentuximab Vedotin with Chemotherapy in Adolescents and Young Adults (AYAs) With Stage III or IV Hodgkin Lymphoma: a Subgroup Analysis From the Phase 3 ECHELON-1 Study